MedPath

Trimethoprim sulfate and Polymyxin B sulfate

Trimethoprim Sulfate and Polymyxin B Sulfate Ophthalmic Solution

Approved
Approval ID

2c5579eb-ad81-415e-8dcb-9f1c94c897ae

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 1, 2021

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Trimethoprim sulfate and Polymyxin B sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63187-193
Application NumberANDA065006
Product Classification
M
Marketing Category
C73584
G
Generic Name
Trimethoprim sulfate and Polymyxin B sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 1, 2021
FDA Product Classification

INGREDIENTS (7)

sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
sulfuric acidInactive
Code: O40UQP6WCF
Classification: IACT
Polymyxin B sulfateActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIM
benzalkonium chlorideInactive
Code: F5UM2KM3W7
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
Trimethoprim sulfateActive
Quantity: 1 mg in 1 mL
Code: E377MF8EQ8
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Trimethoprim sulfate and Polymyxin B sulfate - FDA Drug Approval Details